Literature DB >> 33015794

LncRNA SNHG16 drives proliferation, migration, and invasion of lung cancer cell through modulation of miR-520/VEGF axis.

L Chen1, C-H Qiu, Y Chen, Y Wang, J-J Zhao, M Zhang.   

Abstract

OBJECTIVE: Long non-coding RNAs (lncRNAs) have been shown to have important effects on various biological behavior of human diseases. Although increasing lncRNAs have been explored in human cancers, there are still countless lncRNA to be mined. The purpose of this study was to investigate the effect of lncRNA SNHG16 on the proliferation and metastasis of lung cancer cells. PATIENTS AND METHODS: RT-qPCR was used to analyze the expression patterns of SNHG16, miR-520 and VEGF. MTT and transwell methods were used to detect the effect of SNHG16 on cell migration. The association between SNHG16, miR-520 and VEGF was analyzed by bioinformatics analysis and Dual-Luciferase verification reporter analysis. Finally, lung cancer cells have demonstrated the role of SNHG16-miR-520-VEGF in the cell biological behavior axis.
RESULTS: Compared with normal cells, SNHG16 is highly expressed in lung cancer cells. Silent SNHG16 has a negative effect on the migration of lung cancer cells.
CONCLUSIONS: LncRNA SNHG16 as ceRNA up-regulates VEGF in lung cancer cells by binding to miR-520. LncRNA SNHG16 as ceRNA promotes the migration of lung cancer cells by regulating the miR-520/VEGF axis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015794     DOI: 10.26355/eurrev_202009_23037

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Long Intergenic Non-Protein Coding RNA 519 Promotes the Biological Activities of Tongue Squamous Cell Carcinoma by Sponging microRNA-876-3p and Consequently Upregulating MACC1.

Authors:  Dejun Liu; Jing Zhao; Huiling Wang; Hui Li; Yanjie Li; Wangsen Qin
Journal:  Onco Targets Ther       Date:  2020-11-20       Impact factor: 4.147

2.  Long Noncoding RNA SNHG16 Regulates the Growth of Human Lung Cancer Cells by Modulating the Expression of Aldehyde Dehydrogenase 2 (ALDH2).

Authors:  Yan Li; Lifeng Jiang; Zhaocheng Zhu; Binfan Fu; Xu Sun; Yue Jiao
Journal:  J Oncol       Date:  2022-05-20       Impact factor: 4.501

Review 3.  RNA-based therapies: A cog in the wheel of lung cancer defense.

Authors:  Parvez Khan; Jawed Akhtar Siddiqui; Imayavaramban Lakshmanan; Apar Kishor Ganti; Ravi Salgia; Maneesh Jain; Surinder Kumar Batra; Mohd Wasim Nasser
Journal:  Mol Cancer       Date:  2021-03-19       Impact factor: 27.401

4.  Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6.

Authors:  Fushun Li; Xianghua Sun; Qing Liu; Xilu Liu; Jia Zhang
Journal:  Gastroenterol Res Pract       Date:  2021-07-30       Impact factor: 2.260

5.  NORAD Promotes the Viability, Migration, and Phenotypic Switch of Human Vascular Smooth Muscle Cells during Aortic Dissection via LIN28B-Mediated TGF-β Promotion and Subsequent Enhanced Glycolysis.

Authors:  Shi-Bo Xia; Zhuang-Bo Tian; Wenbo Zhang; Hao Zhang
Journal:  Biomed Res Int       Date:  2022-08-06       Impact factor: 3.246

6.  A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.

Authors:  Enmin Huang; Tao Ma; Junyi Zhou; Ning Ma; Weisheng Yang; Chuangxiong Liu; Zehui Hou; Shuang Chen; Zhen Zong; Bing Zeng; Yingru Li; Taicheng Zhou
Journal:  J Gastrointest Oncol       Date:  2022-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.